♟️ Monday 25 August 2025 Mon, 25 Aug 2025

Metals X Limited reported a robust half-year to June 2025 with profit after tax soaring 256% to $52.9 million, driven by higher tin sales and prices from its Renison joint venture. The company also progressed key projects and deepened strategic investments while reinforcing its ESG and safety frameworks.

Acrow Limited reports a record FY25 with sales up 23%, driven by an 83% jump in its Industrial Access division, now half of group revenue. Despite soft formwork markets, strategic acquisitions and growth initiatives underpin a confident outlook.

Actinogen Medical reports steady progress in its Alzheimer’s and depression drug trials, backed by strong funding and strategic commercial planning. Key interim data from the pivotal XanaMIA trial is expected early next year.

Actinogen Medical reported a $14.7 million net loss for FY25 while progressing its lead drug Xanamem through pivotal Alzheimer’s and depression trials, with interim results expected in January 2026. The company has secured funding through mid-2026 and is preparing for commercialization.

Platinum Asia Investments has finalized its scheme of arrangement, transferring shares to an ETF structure and delisting from the ASX. Shareholders now hold units in the Platinum Asia Fund Complex ETF as the company undergoes a significant restructure.

Supply Network Limited reported a robust 15.5% revenue increase to $349.9 million and a 21.2% rise in profit after tax to $40 million for FY2025, alongside a higher fully franked final dividend of 38 cents per share.

Symal Group Limited reported a robust FY25 with revenue and earnings growth exceeding Prospectus forecasts, underpinned by strategic acquisitions and a strong pipeline of contracts.

Symal Group Limited reports a strong first year as an ASX-listed company, exceeding earnings forecasts and advancing its growth through key acquisitions and sustainability initiatives.

Platinum Capital Limited reported a 24% drop in net profit for FY2025, underperforming its benchmark, while announcing a strategic withdrawal of a merger scheme and initiating a substantial share buy-back alongside significant board changes.

Platinum Asia Investments Limited reported a robust 226% increase in net profit for FY2025, alongside a strategic Scheme of Arrangement to restructure and delist the company from the ASX.

Clime Capital Limited reported a 29% drop in net profit for FY25 but maintained its quarterly dividends and rolled over convertible notes with enhanced terms. The company is pivoting towards a debt-focused portfolio to boost income stability.

The Australian Wealth Advisors Group Ltd (AWAG) reported a 13% revenue increase and a $1.2 million profit before tax in FY2025, driven by strategic Equity Partnership Scheme investments and a strong funds under management base.

Desane Group Holdings Limited reported a strong FY25 with net profit after tax doubling to $3.3 million, supported by a $6.2 million uplift in property valuations and key lease extensions securing future rental income.

Asset Vision reported robust FY25 results with significant revenue and cash flow growth, achieving a debt-free status while advancing its AI-powered asset management platform.

Asset Vision Co Limited reported a 22.9% increase in revenue to $5.03 million for FY2025, alongside a widening net loss of $385,797. The company’s Annual Recurring Revenue surged 28%, supported by new contracts and product innovation.

Polynovo Limited reported a robust 23.3% increase in total revenue for FY25, driven by strong commercial sales growth across the US and international markets. The company is advancing its FDA PMA submission and expanding its global footprint amid strategic product development.

PolyNovo Limited reported a robust 28.9% increase in group sales to A$118.6 million for FY25, alongside a 151% surge in net profit after tax to A$13.2 million, driven by strong U.S. growth and key regulatory approvals.

Gold Road Resources has dispatched its Scheme Booklet to shareholders detailing the proposed acquisition by Gold Fields. The Board unanimously recommends approval, setting the stage for a pivotal shareholder vote in September.

Kogan.com announces the appointment of three seasoned independent directors as part of a strategic board renewal, while confirming a planned chairman transition in 2026.

Vital Metals has raised A$6.8 million through a strategic placement led by US-based Strategic Resources LLC to advance its Tardiff Rare Earth project in Canada, aiming to deploy innovative Dry Field Force Extraction technology that could reshape project economics and environmental impact.

Kogan.com Ltd reported robust FY25 growth with a 35% increase in active customers and a 20.5% rise in platform sales revenue, offset by a significant goodwill impairment at subsidiary Mighty Ape. The group declared a 7.0 cent final dividend and announced key board changes.

InhaleRx Limited reported a widening half-year loss as it accelerates clinical trials for inhaled drug-device therapies, supported by a substantial $38.5 million funding facility.

360 Capital Group reported a remarkable 1394% increase in statutory profit for FY25, maintaining dividends while advancing its real estate credit platform and announcing a substantial special distribution.

G50 Corp has raised A$10 million through a well-supported institutional placement to fund extensive drilling and metallurgical testing at its Golconda project in Arizona, targeting strategic minerals including gallium.